chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Antinuclear antibody negative, Arthralgia, Back pain, Blood uric acid normal, C-reactive protein increased
Clinical narrative: Arm rash; fever for a week; extreme fatigue that was progressive just as the brain fog; extreme fatigue that was progressive just as the brain fog; parasthesias all over body; sweats; chest pain/pressure; chest pain/pressure; shortness of breath; rattling sound in throat; difficulty swallowing; choking; neck pain; head and chest pressure; elevated blood pressure; low pulse and oxygenation; low pulse and oxygenation; spine and hip pain; spine and hip pain; left lower leg and foot swelling; This is a spontaneous report from a contactable Nurse reporting for herself   A 50-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), on 09Jan2021  at 16:30 via an unspecified route of administration, in Arm Right at single dose for covid-19 immunisation.  Medical history included perennial allergy, hot flush and vitamin d decreased. Concomitant medications included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported; montelukast sodium (SINGULAIR),  mometasone furoate (FLONASE [MOMETASONE FUROATE]), escitalopram.  The patient previously took demerol and experienced drug hypersensitivity, hydrocodone and experienced vomiting and dizziness.  The patient received first dose of BNT162B2 on 22Dec2020 at 11:15 pm. On 09Jan2021  at 20:00 the patient experienced Arm rash, fever for a week, extreme fatigue that was progressive just as the brain fog, parasthesias all over body, sweats, chest pain/pressure, shortness of breath, rattling sound in throat, difficulty swallowing, choking, neck pain, head and chest pressure, elevated blood pressure, low pulse and oxygenation, spine and hip pain, left lower leg and foot swelling. All the events were assessed serious as disabling. At the time of the reporting the patient had not yet recovered from the events.   The information on the lot/batch number has been requested.; Sender's Comments: Based on the current available information and the strong drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Full blood count, Metabolic function test, Pain, Pain in extremity, Pyrexia
Clinical narrative: Arm rash; fever for a week; extreme fatigue that was progressive just as the brain fog; extreme fatigue that was progressive just as the brain fog; parasthesias all over body; sweats; chest pain/pressure; chest pain/pressure; shortness of breath; rattling sound in throat; difficulty swallowing; choking; neck pain; head and chest pressure; elevated blood pressure; low pulse and oxygenation; low pulse and oxygenation; spine and hip pain; spine and hip pain; left lower leg and foot swelling; This is a spontaneous report from a contactable Nurse reporting for herself   A 50-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), on 09Jan2021  at 16:30 via an unspecified route of administration, in Arm Right at single dose for covid-19 immunisation.  Medical history included perennial allergy, hot flush and vitamin d decreased. Concomitant medications included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported; montelukast sodium (SINGULAIR),  mometasone furoate (FLONASE [MOMETASONE FUROATE]), escitalopram.  The patient previously took demerol and experienced drug hypersensitivity, hydrocodone and experienced vomiting and dizziness.  The patient received first dose of BNT162B2 on 22Dec2020 at 11:15 pm. On 09Jan2021  at 20:00 the patient experienced Arm rash, fever for a week, extreme fatigue that was progressive just as the brain fog, parasthesias all over body, sweats, chest pain/pressure, shortness of breath, rattling sound in throat, difficulty swallowing, choking, neck pain, head and chest pressure, elevated blood pressure, low pulse and oxygenation, spine and hip pain, left lower leg and foot swelling. All the events were assessed serious as disabling. At the time of the reporting the patient had not yet recovered from the events.   The information on the lot/batch number has been requested.; Sender's Comments: Based on the current available information and the strong drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Red blood cell sedimentation rate increased, Renal pain, SARS-CoV-2 test negative, Spinal pain, Streptococcus test negative
Clinical narrative: Arm rash; fever for a week; extreme fatigue that was progressive just as the brain fog; extreme fatigue that was progressive just as the brain fog; parasthesias all over body; sweats; chest pain/pressure; chest pain/pressure; shortness of breath; rattling sound in throat; difficulty swallowing; choking; neck pain; head and chest pressure; elevated blood pressure; low pulse and oxygenation; low pulse and oxygenation; spine and hip pain; spine and hip pain; left lower leg and foot swelling; This is a spontaneous report from a contactable Nurse reporting for herself   A 50-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), on 09Jan2021  at 16:30 via an unspecified route of administration, in Arm Right at single dose for covid-19 immunisation.  Medical history included perennial allergy, hot flush and vitamin d decreased. Concomitant medications included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported; montelukast sodium (SINGULAIR),  mometasone furoate (FLONASE [MOMETASONE FUROATE]), escitalopram.  The patient previously took demerol and experienced drug hypersensitivity, hydrocodone and experienced vomiting and dizziness.  The patient received first dose of BNT162B2 on 22Dec2020 at 11:15 pm. On 09Jan2021  at 20:00 the patient experienced Arm rash, fever for a week, extreme fatigue that was progressive just as the brain fog, parasthesias all over body, sweats, chest pain/pressure, shortness of breath, rattling sound in throat, difficulty swallowing, choking, neck pain, head and chest pressure, elevated blood pressure, low pulse and oxygenation, spine and hip pain, left lower leg and foot swelling. All the events were assessed serious as disabling. At the time of the reporting the patient had not yet recovered from the events.   The information on the lot/batch number has been requested.; Sender's Comments: Based on the current available information and the strong drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Blood pressure increased, Chest discomfort, Chest pain, Choking
Clinical narrative: Arm rash; fever for a week; extreme fatigue that was progressive just as the brain fog; extreme fatigue that was progressive just as the brain fog; parasthesias all over body; sweats; chest pain/pressure; chest pain/pressure; shortness of breath; rattling sound in throat; difficulty swallowing; choking; neck pain; head and chest pressure; elevated blood pressure; low pulse and oxygenation; low pulse and oxygenation; spine and hip pain; spine and hip pain; left lower leg and foot swelling; This is a spontaneous report from a contactable Nurse reporting for herself   A 50-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), on 09Jan2021  at 16:30 via an unspecified route of administration, in Arm Right at single dose for covid-19 immunisation.  Medical history included perennial allergy, hot flush and vitamin d decreased. Concomitant medications included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported; montelukast sodium (SINGULAIR),  mometasone furoate (FLONASE [MOMETASONE FUROATE]), escitalopram.  The patient previously took demerol and experienced drug hypersensitivity, hydrocodone and experienced vomiting and dizziness.  The patient received first dose of BNT162B2 on 22Dec2020 at 11:15 pm. On 09Jan2021  at 20:00 the patient experienced Arm rash, fever for a week, extreme fatigue that was progressive just as the brain fog, parasthesias all over body, sweats, chest pain/pressure, shortness of breath, rattling sound in throat, difficulty swallowing, choking, neck pain, head and chest pressure, elevated blood pressure, low pulse and oxygenation, spine and hip pain, left lower leg and foot swelling. All the events were assessed serious as disabling. At the time of the reporting the patient had not yet recovered from the events.   The information on the lot/batch number has been requested.; Sender's Comments: Based on the current available information and the strong drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphagia, Dyspnoea, Fatigue, Feeling abnormal, Head discomfort
Clinical narrative: Arm rash; fever for a week; extreme fatigue that was progressive just as the brain fog; extreme fatigue that was progressive just as the brain fog; parasthesias all over body; sweats; chest pain/pressure; chest pain/pressure; shortness of breath; rattling sound in throat; difficulty swallowing; choking; neck pain; head and chest pressure; elevated blood pressure; low pulse and oxygenation; low pulse and oxygenation; spine and hip pain; spine and hip pain; left lower leg and foot swelling; This is a spontaneous report from a contactable Nurse reporting for herself   A 50-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), on 09Jan2021  at 16:30 via an unspecified route of administration, in Arm Right at single dose for covid-19 immunisation.  Medical history included perennial allergy, hot flush and vitamin d decreased. Concomitant medications included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported; montelukast sodium (SINGULAIR),  mometasone furoate (FLONASE [MOMETASONE FUROATE]), escitalopram.  The patient previously took demerol and experienced drug hypersensitivity, hydrocodone and experienced vomiting and dizziness.  The patient received first dose of BNT162B2 on 22Dec2020 at 11:15 pm. On 09Jan2021  at 20:00 the patient experienced Arm rash, fever for a week, extreme fatigue that was progressive just as the brain fog, parasthesias all over body, sweats, chest pain/pressure, shortness of breath, rattling sound in throat, difficulty swallowing, choking, neck pain, head and chest pressure, elevated blood pressure, low pulse and oxygenation, spine and hip pain, left lower leg and foot swelling. All the events were assessed serious as disabling. At the time of the reporting the patient had not yet recovered from the events.   The information on the lot/batch number has been requested.; Sender's Comments: Based on the current available information and the strong drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate decreased, Hyperhidrosis, Neck pain, Oropharyngeal discomfort, Oxygen saturation decreased
Clinical narrative: Arm rash; fever for a week; extreme fatigue that was progressive just as the brain fog; extreme fatigue that was progressive just as the brain fog; parasthesias all over body; sweats; chest pain/pressure; chest pain/pressure; shortness of breath; rattling sound in throat; difficulty swallowing; choking; neck pain; head and chest pressure; elevated blood pressure; low pulse and oxygenation; low pulse and oxygenation; spine and hip pain; spine and hip pain; left lower leg and foot swelling; This is a spontaneous report from a contactable Nurse reporting for herself   A 50-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), on 09Jan2021  at 16:30 via an unspecified route of administration, in Arm Right at single dose for covid-19 immunisation.  Medical history included perennial allergy, hot flush and vitamin d decreased. Concomitant medications included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported; montelukast sodium (SINGULAIR),  mometasone furoate (FLONASE [MOMETASONE FUROATE]), escitalopram.  The patient previously took demerol and experienced drug hypersensitivity, hydrocodone and experienced vomiting and dizziness.  The patient received first dose of BNT162B2 on 22Dec2020 at 11:15 pm. On 09Jan2021  at 20:00 the patient experienced Arm rash, fever for a week, extreme fatigue that was progressive just as the brain fog, parasthesias all over body, sweats, chest pain/pressure, shortness of breath, rattling sound in throat, difficulty swallowing, choking, neck pain, head and chest pressure, elevated blood pressure, low pulse and oxygenation, spine and hip pain, left lower leg and foot swelling. All the events were assessed serious as disabling. At the time of the reporting the patient had not yet recovered from the events.   The information on the lot/batch number has been requested.; Sender's Comments: Based on the current available information and the strong drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Peripheral swelling, Pyrexia, Rash, SARS-CoV-2 antibody test
Clinical narrative: Arm rash; fever for a week; extreme fatigue that was progressive just as the brain fog; extreme fatigue that was progressive just as the brain fog; parasthesias all over body; sweats; chest pain/pressure; chest pain/pressure; shortness of breath; rattling sound in throat; difficulty swallowing; choking; neck pain; head and chest pressure; elevated blood pressure; low pulse and oxygenation; low pulse and oxygenation; spine and hip pain; spine and hip pain; left lower leg and foot swelling; This is a spontaneous report from a contactable Nurse reporting for herself   A 50-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), on 09Jan2021  at 16:30 via an unspecified route of administration, in Arm Right at single dose for covid-19 immunisation.  Medical history included perennial allergy, hot flush and vitamin d decreased. Concomitant medications included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported; montelukast sodium (SINGULAIR),  mometasone furoate (FLONASE [MOMETASONE FUROATE]), escitalopram.  The patient previously took demerol and experienced drug hypersensitivity, hydrocodone and experienced vomiting and dizziness.  The patient received first dose of BNT162B2 on 22Dec2020 at 11:15 pm. On 09Jan2021  at 20:00 the patient experienced Arm rash, fever for a week, extreme fatigue that was progressive just as the brain fog, parasthesias all over body, sweats, chest pain/pressure, shortness of breath, rattling sound in throat, difficulty swallowing, choking, neck pain, head and chest pressure, elevated blood pressure, low pulse and oxygenation, spine and hip pain, left lower leg and foot swelling. All the events were assessed serious as disabling. At the time of the reporting the patient had not yet recovered from the events.   The information on the lot/batch number has been requested.; Sender's Comments: Based on the current available information and the strong drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Spinal pain
Clinical narrative: Arm rash; fever for a week; extreme fatigue that was progressive just as the brain fog; extreme fatigue that was progressive just as the brain fog; parasthesias all over body; sweats; chest pain/pressure; chest pain/pressure; shortness of breath; rattling sound in throat; difficulty swallowing; choking; neck pain; head and chest pressure; elevated blood pressure; low pulse and oxygenation; low pulse and oxygenation; spine and hip pain; spine and hip pain; left lower leg and foot swelling; This is a spontaneous report from a contactable Nurse reporting for herself   A 50-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), on 09Jan2021  at 16:30 via an unspecified route of administration, in Arm Right at single dose for covid-19 immunisation.  Medical history included perennial allergy, hot flush and vitamin d decreased. Concomitant medications included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported; montelukast sodium (SINGULAIR),  mometasone furoate (FLONASE [MOMETASONE FUROATE]), escitalopram.  The patient previously took demerol and experienced drug hypersensitivity, hydrocodone and experienced vomiting and dizziness.  The patient received first dose of BNT162B2 on 22Dec2020 at 11:15 pm. On 09Jan2021  at 20:00 the patient experienced Arm rash, fever for a week, extreme fatigue that was progressive just as the brain fog, parasthesias all over body, sweats, chest pain/pressure, shortness of breath, rattling sound in throat, difficulty swallowing, choking, neck pain, head and chest pressure, elevated blood pressure, low pulse and oxygenation, spine and hip pain, left lower leg and foot swelling. All the events were assessed serious as disabling. At the time of the reporting the patient had not yet recovered from the events.   The information on the lot/batch number has been requested.; Sender's Comments: Based on the current available information and the strong drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Headache, Myalgia, Nausea
Clinical narrative: muscle and severe joint pain, chills, headache; muscle and severe joint pain, chills, headache; muscle and severe joint pain, chills, headache; muscle and severe joint pain, chills, headache; This is a spontaneous report from a contactable consumer. This 66-years-old female consumer (patient) reported that: A 66-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EL9266), via an unspecified route of administration, administered in Arm Left on 17Feb2021 at 18:30 (at the age of 66-year-old) as single dose for covid-19 immunisation. Medical history included mild osteoarthritis and rheumatoid arthritis from an unknown date and unknown if ongoing. Patient had no known allergies. Patient not diagnosed with covid-19 prior to vaccination. Concomitant medication(s) included cholecalciferol (D3); omega 6 triglycerides, omega 9 triglycerides, omega-3 triglycerides (OMEGA 3-6-9); coenzyme q10 [ubidecarenone] (COENZYME Q10 [UBIDECARENONE]) and multivitamin taken for an unspecified indication, start and stop date were not reported. Patient's historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EL9265), via an unspecified route of administration, administered in Arm Left on 27Jan2021at 18:45 (at the age of 66-year-old) as single dose for covid-19 immunisation. Patient was not received any other vaccine four weeks prior vaccination. The patient experienced muscle and severe joint pain, chills, headache on 18Feb2021 at 10:00. Since vaccination patient not tested for covid-19. No therapeutic measures were taken as a result of the events. The outcome of the events was reported as recovering.  Follow-up attempts completed. No further information expected.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Headache, Myalgia
Clinical narrative: muscle and severe joint pain, chills, headache; muscle and severe joint pain, chills, headache; muscle and severe joint pain, chills, headache; muscle and severe joint pain, chills, headache; This is a spontaneous report from a contactable consumer. This 66-years-old female consumer (patient) reported that: A 66-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EL9266), via an unspecified route of administration, administered in Arm Left on 17Feb2021 at 18:30 (at the age of 66-year-old) as single dose for covid-19 immunisation. Medical history included mild osteoarthritis and rheumatoid arthritis from an unknown date and unknown if ongoing. Patient had no known allergies. Patient not diagnosed with covid-19 prior to vaccination. Concomitant medication(s) included cholecalciferol (D3); omega 6 triglycerides, omega 9 triglycerides, omega-3 triglycerides (OMEGA 3-6-9); coenzyme q10 [ubidecarenone] (COENZYME Q10 [UBIDECARENONE]) and multivitamin taken for an unspecified indication, start and stop date were not reported. Patient's historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EL9265), via an unspecified route of administration, administered in Arm Left on 27Jan2021at 18:45 (at the age of 66-year-old) as single dose for covid-19 immunisation. Patient was not received any other vaccine four weeks prior vaccination. The patient experienced muscle and severe joint pain, chills, headache on 18Feb2021 at 10:00. Since vaccination patient not tested for covid-19. No therapeutic measures were taken as a result of the events. The outcome of the events was reported as recovering.  Follow-up attempts completed. No further information expected.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Blood pressure increased, Burning sensation, Depression, Dizziness
Clinical narrative: great difficulty thinking; brain problems; confusion; loss of thought; physical pain; Rapid thought; This is a spontaneous report from a contactable consumer. A 69-year-old female consumer (patient) reported for herself that she received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular single dose in Mar2021 for COVID-19 immunization at age of 69 years old. Medical history included chronic Lyme disease. Concomitant drugs were not provided.  She had some side effects 2 weeks after the dose that included; brain problems, great difficulty thinking, confusion, loss of thought, rapid thought, and physical pain. She did not receive her second dose within 3 weeks of the first. She has been speaking with her doctor about the possibility of receiving the second dose and/or the booster dose when it is available.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Fatigue, Irritability, Language disorder, Muscular weakness
Clinical narrative: great difficulty thinking; brain problems; confusion; loss of thought; physical pain; Rapid thought; This is a spontaneous report from a contactable consumer. A 69-year-old female consumer (patient) reported for herself that she received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular single dose in Mar2021 for COVID-19 immunization at age of 69 years old. Medical history included chronic Lyme disease. Concomitant drugs were not provided.  She had some side effects 2 weeks after the dose that included; brain problems, great difficulty thinking, confusion, loss of thought, rapid thought, and physical pain. She did not receive her second dose within 3 weeks of the first. She has been speaking with her doctor about the possibility of receiving the second dose and/or the booster dose when it is available.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea
Clinical narrative: great difficulty thinking; brain problems; confusion; loss of thought; physical pain; Rapid thought; This is a spontaneous report from a contactable consumer. A 69-year-old female consumer (patient) reported for herself that she received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular single dose in Mar2021 for COVID-19 immunization at age of 69 years old. Medical history included chronic Lyme disease. Concomitant drugs were not provided.  She had some side effects 2 weeks after the dose that included; brain problems, great difficulty thinking, confusion, loss of thought, rapid thought, and physical pain. She did not receive her second dose within 3 weeks of the first. She has been speaking with her doctor about the possibility of receiving the second dose and/or the booster dose when it is available.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebral disorder, Confusional state, Mental impairment, Pain, Tachyphrenia
Clinical narrative: great difficulty thinking; brain problems; confusion; loss of thought; physical pain; Rapid thought; This is a spontaneous report from a contactable consumer. A 69-year-old female consumer (patient) reported for herself that she received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular single dose in Mar2021 for COVID-19 immunization at age of 69 years old. Medical history included chronic Lyme disease. Concomitant drugs were not provided.  She had some side effects 2 weeks after the dose that included; brain problems, great difficulty thinking, confusion, loss of thought, rapid thought, and physical pain. She did not receive her second dose within 3 weeks of the first. She has been speaking with her doctor about the possibility of receiving the second dose and/or the booster dose when it is available.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Thought blocking
Clinical narrative: great difficulty thinking; brain problems; confusion; loss of thought; physical pain; Rapid thought; This is a spontaneous report from a contactable consumer. A 69-year-old female consumer (patient) reported for herself that she received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular single dose in Mar2021 for COVID-19 immunization at age of 69 years old. Medical history included chronic Lyme disease. Concomitant drugs were not provided.  She had some side effects 2 weeks after the dose that included; brain problems, great difficulty thinking, confusion, loss of thought, rapid thought, and physical pain. She did not receive her second dose within 3 weeks of the first. She has been speaking with her doctor about the possibility of receiving the second dose and/or the booster dose when it is available.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Back pain, Neck pain, Pain in extremity
Clinical narrative: severe pain on his neck, back, left side, and his thighs/has had increasing aching in his neck and shoulders, and pain in his back and along his left side; severe pain on his neck, back, left side, and his thighs/has had increasing aching in his neck and shoulders, and pain in his back and along his left side; This is a spontaneous report from a Contactable consumer via Medical Information Team. A 74-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6201; Expiration Date: Jun2021) via an unspecified route of administration, administered in Arm Left on 16Feb2021 (age at vaccination was reported as 74 years) DOSE 2, SINGLE for covid-19 immunisation. Medical history included lung transplant on an unspecified date (Both lungs, exactly 11 months ago) and anaemia from an unknown date and unknown if ongoing. Concomitant medication included iron taken for anaemia, start and stop date were not reported. Historical vaccine included dose 1, single of bnt162b2 on 26Jan2021 (lot number was EL9262, and the expiry date was May2021, age at vaccination was 74 years) for COVID-19 immunization and experienced sleepy. On 18Feb2021, the patient experienced severe pain on his neck, back, left side, and his thighs/has had increasing aching in his neck and shoulders, and pain in his back and along his left side. It was reported that patient received the 2nd shot on 16Feb2021. He experienced severe pain on his neck, back, left side, and his thighs/ increasing aching in his neck and shoulders, and pain in his back and along his left sides. It was really bad that he took hydrocodone. He mentioned that he was a transplant patient and had not taken these medications since his surgery. The patient had his shot on 16Feb2021, and the next day he slept, he got up for coffee and then went to bed for 5 hours. patient states that yesterday morning, he started having the neck and back and side aches, and they have progressively worsened, and they were bad this morning and he took 5 mg of Hydrocodone, and it has started to kick in. The patient underwent lab tests and procedures which included blood test results were unknown on an unspecified date. The clinical outcome of the events was not resolved.   No follow up attempts are possible. No further information is expected.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Back pain, Blood test, Neck pain
Clinical narrative: severe pain on his neck, back, left side, and his thighs/has had increasing aching in his neck and shoulders, and pain in his back and along his left side; severe pain on his neck, back, left side, and his thighs/has had increasing aching in his neck and shoulders, and pain in his back and along his left side; This is a spontaneous report from a Contactable consumer via Medical Information Team. A 74-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6201; Expiration Date: Jun2021) via an unspecified route of administration, administered in Arm Left on 16Feb2021 (age at vaccination was reported as 74 years) DOSE 2, SINGLE for covid-19 immunisation. Medical history included lung transplant on an unspecified date (Both lungs, exactly 11 months ago) and anaemia from an unknown date and unknown if ongoing. Concomitant medication included iron taken for anaemia, start and stop date were not reported. Historical vaccine included dose 1, single of bnt162b2 on 26Jan2021 (lot number was EL9262, and the expiry date was May2021, age at vaccination was 74 years) for COVID-19 immunization and experienced sleepy. On 18Feb2021, the patient experienced severe pain on his neck, back, left side, and his thighs/has had increasing aching in his neck and shoulders, and pain in his back and along his left side. It was reported that patient received the 2nd shot on 16Feb2021. He experienced severe pain on his neck, back, left side, and his thighs/ increasing aching in his neck and shoulders, and pain in his back and along his left sides. It was really bad that he took hydrocodone. He mentioned that he was a transplant patient and had not taken these medications since his surgery. The patient had his shot on 16Feb2021, and the next day he slept, he got up for coffee and then went to bed for 5 hours. patient states that yesterday morning, he started having the neck and back and side aches, and they have progressively worsened, and they were bad this morning and he took 5 mg of Hydrocodone, and it has started to kick in. The patient underwent lab tests and procedures which included blood test results were unknown on an unspecified date. The clinical outcome of the events was not resolved.   No follow up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anti-cyclic citrullinated peptide antibody, Antinuclear antibody negative, Basophil count normal, Basophil percentage, C-reactive protein increased
Clinical narrative: anemic; Severe fatigue; inflamed lymphatic system; arthritic pain; muscle twitching; This is a spontaneous report from a contactable consumer. This consumer reported for a 29-year-old female patient (reporter's daughter) that.  A 29-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 27Jan2021 as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced severe fatigue, inflamed lymphatic system, arthritic pain, muscle twitching on 29Jan2021, patient experienced anemic on an unspecified date. It was reported that reporter daughter has had a severe adverse reaction to the covid vaccine first shot which she got 5 weeks ago. Her medical providers have done blood tests and do not know how to treat this. Her doctor does not know what to do. He also mentioned she had blood work done and was anaemic. Her Doctor said we are going to pump you a steroid. Reporter stated, The patient underwent lab tests and procedures which included blood work done result: anemic on an unknown date. The outcome if events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Eosinophil count decreased, Eosinophil percentage, Haematocrit normal, Haemoglobin normal, Lymphadenopathy
Clinical narrative: anemic; Severe fatigue; inflamed lymphatic system; arthritic pain; muscle twitching; This is a spontaneous report from a contactable consumer. This consumer reported for a 29-year-old female patient (reporter's daughter) that.  A 29-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 27Jan2021 as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced severe fatigue, inflamed lymphatic system, arthritic pain, muscle twitching on 29Jan2021, patient experienced anemic on an unspecified date. It was reported that reporter daughter has had a severe adverse reaction to the covid vaccine first shot which she got 5 weeks ago. Her medical providers have done blood tests and do not know how to treat this. Her doctor does not know what to do. He also mentioned she had blood work done and was anaemic. Her Doctor said we are going to pump you a steroid. Reporter stated, The patient underwent lab tests and procedures which included blood work done result: anemic on an unknown date. The outcome if events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lymphocyte count, Lymphocyte percentage, Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal, Mean cell volume normal
Clinical narrative: anemic; Severe fatigue; inflamed lymphatic system; arthritic pain; muscle twitching; This is a spontaneous report from a contactable consumer. This consumer reported for a 29-year-old female patient (reporter's daughter) that.  A 29-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 27Jan2021 as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced severe fatigue, inflamed lymphatic system, arthritic pain, muscle twitching on 29Jan2021, patient experienced anemic on an unspecified date. It was reported that reporter daughter has had a severe adverse reaction to the covid vaccine first shot which she got 5 weeks ago. Her medical providers have done blood tests and do not know how to treat this. Her doctor does not know what to do. He also mentioned she had blood work done and was anaemic. Her Doctor said we are going to pump you a steroid. Reporter stated, The patient underwent lab tests and procedures which included blood work done result: anemic on an unknown date. The outcome if events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mean platelet volume normal, Monocyte count, Monocyte percentage, Neutrophil count, Neutrophil percentage
Clinical narrative: anemic; Severe fatigue; inflamed lymphatic system; arthritic pain; muscle twitching; This is a spontaneous report from a contactable consumer. This consumer reported for a 29-year-old female patient (reporter's daughter) that.  A 29-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 27Jan2021 as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced severe fatigue, inflamed lymphatic system, arthritic pain, muscle twitching on 29Jan2021, patient experienced anemic on an unspecified date. It was reported that reporter daughter has had a severe adverse reaction to the covid vaccine first shot which she got 5 weeks ago. Her medical providers have done blood tests and do not know how to treat this. Her doctor does not know what to do. He also mentioned she had blood work done and was anaemic. Her Doctor said we are going to pump you a steroid. Reporter stated, The patient underwent lab tests and procedures which included blood work done result: anemic on an unknown date. The outcome if events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Platelet count increased, Red blood cell count normal, Red blood cell sedimentation rate normal, Red cell distribution width normal, White blood cell count normal
Clinical narrative: anemic; Severe fatigue; inflamed lymphatic system; arthritic pain; muscle twitching; This is a spontaneous report from a contactable consumer. This consumer reported for a 29-year-old female patient (reporter's daughter) that.  A 29-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 27Jan2021 as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced severe fatigue, inflamed lymphatic system, arthritic pain, muscle twitching on 29Jan2021, patient experienced anemic on an unspecified date. It was reported that reporter daughter has had a severe adverse reaction to the covid vaccine first shot which she got 5 weeks ago. Her medical providers have done blood tests and do not know how to treat this. Her doctor does not know what to do. He also mentioned she had blood work done and was anaemic. Her Doctor said we are going to pump you a steroid. Reporter stated, The patient underwent lab tests and procedures which included blood work done result: anemic on an unknown date. The outcome if events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, C-reactive protein, C-reactive protein increased, Lymphadenopathy, Neuralgia
Clinical narrative: anemic; Severe fatigue; inflamed lymphatic system; arthritic pain; muscle twitching; This is a spontaneous report from a contactable consumer. This consumer reported for a 29-year-old female patient (reporter's daughter) that.  A 29-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 27Jan2021 as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced severe fatigue, inflamed lymphatic system, arthritic pain, muscle twitching on 29Jan2021, patient experienced anemic on an unspecified date. It was reported that reporter daughter has had a severe adverse reaction to the covid vaccine first shot which she got 5 weeks ago. Her medical providers have done blood tests and do not know how to treat this. Her doctor does not know what to do. He also mentioned she had blood work done and was anaemic. Her Doctor said we are going to pump you a steroid. Reporter stated, The patient underwent lab tests and procedures which included blood work done result: anemic on an unknown date. The outcome if events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: anemic; Severe fatigue; inflamed lymphatic system; arthritic pain; muscle twitching; This is a spontaneous report from a contactable consumer. This consumer reported for a 29-year-old female patient (reporter's daughter) that.  A 29-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 27Jan2021 as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced severe fatigue, inflamed lymphatic system, arthritic pain, muscle twitching on 29Jan2021, patient experienced anemic on an unspecified date. It was reported that reporter daughter has had a severe adverse reaction to the covid vaccine first shot which she got 5 weeks ago. Her medical providers have done blood tests and do not know how to treat this. Her doctor does not know what to do. He also mentioned she had blood work done and was anaemic. Her Doctor said we are going to pump you a steroid. Reporter stated, The patient underwent lab tests and procedures which included blood work done result: anemic on an unknown date. The outcome if events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaemia, Arthralgia, Fatigue, Lymphadenitis, Muscle twitching
Clinical narrative: anemic; Severe fatigue; inflamed lymphatic system; arthritic pain; muscle twitching; This is a spontaneous report from a contactable consumer. This consumer reported for a 29-year-old female patient (reporter's daughter) that.  A 29-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 27Jan2021 as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced severe fatigue, inflamed lymphatic system, arthritic pain, muscle twitching on 29Jan2021, patient experienced anemic on an unspecified date. It was reported that reporter daughter has had a severe adverse reaction to the covid vaccine first shot which she got 5 weeks ago. Her medical providers have done blood tests and do not know how to treat this. Her doctor does not know what to do. He also mentioned she had blood work done and was anaemic. Her Doctor said we are going to pump you a steroid. Reporter stated, The patient underwent lab tests and procedures which included blood work done result: anemic on an unknown date. The outcome if events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.